Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data-Reference-Cited by-同舟云学术

Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data

Published:2022-03 Issue: Volume:Volume 12 Page:61-73
ISSN:1179-9900
Container-title:Degenerative Neurological and Neuromuscular Disease
language:en
Short-container-title:DNND

Author:

Ruggieri Serena^ORCID,Quartuccio Maria Esmeralda,Prosperini Luca^ORCID

Publisher

Informa UK Limited

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference63 articles.

1. Multiple sclerosis

2. Anon. Number of people with MS | Atlas of MS. Available from: https://www.atlasofms.org/map/global/epidemiology/number-of-people-with-ms. Accessed January 17, 2022.

3. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity

4. Diagnosis and Treatment of Multiple Sclerosis

5. Defining the clinical course of multiple sclerosis: The 2013 revisions

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral oedema as an adverse effect of treatment of secondary progressive multiple sclerosis with siponimod: A case series;Journal of Neuroimmunology;2024-04

2. Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines;Multiple Sclerosis and Related Disorders;2024-03

3. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-01-04

4. Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis;Brain Research;2024-01

5. The role of sphingosine-1-phosphate in the development and progression of Parkinson’s disease;Frontiers in Cellular Neuroscience;2023-12-21